Form 4: Doximity Director Kira Scherer Wampler Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
Director Kira Scherer Wampler exercised stock options and sold 2,500 shares of Doximity Class A Common Stock at $43.44 per share on October 1, 2024, according to a pre-arranged 10b5-1 trading plan.
Summary
- On October 1, 2024, Kira Scherer Wampler, a director of Doximity, Inc. (DOCS), executed a stock option to acquire 2,500 shares of Class A Common Stock.
- Simultaneously, Wampler sold 2,500 shares of Class A Common Stock at a price of $43.44 per share.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on August 24, 2023.
- Following these transactions, Wampler directly owns 16,618 shares of Class A Common Stock and 492,200 shares of Class B Common Stock.
- Wampler also holds options to purchase 0 shares of Class B Common Stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports routine transactions under a pre-existing trading plan. There is no indication of unusual activity or concern.
Future Outlook
The document does not contain specific forward-looking statements, but the Rule 10b5-1 trading plan suggests a pre-determined strategy for future transactions.
Industry Context
Insider transactions are common, and the use of 10b5-1 plans is a standard practice to avoid accusations of trading on non-public information. The sale represents a small percentage of the director's holdings.
Comparison to Industry Standards
- Comparing Wampler's transactions to other directors in similar tech companies, the volume of shares sold is relatively small.
- Many executives use 10b5-1 plans to diversify their holdings over time, similar to practices seen at companies like Teladoc and Veeva Systems.
- The price of $43.44 is within the typical trading range for DOCS, but further analysis would be needed to determine if it represents a significant deviation from the average.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small volume of shares sold.
- The transactions are unlikely to significantly affect employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| March 27, 2020 | Start date for vesting of stock option in 36 equal monthly installments. |
| June 10, 2020 | Date the stock option was granted. |
| August 24, 2023 | Date the Reporting Person adopted the Rule 10b5-1 trading plan. |
| October 01, 2024 | Date of the transaction (exercise of stock option and sale of shares). |
| October 02, 2024 | Date of signature for the Form 4 filing. |
| June 09, 2030 | Expiration date of the stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.